Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indomethacin and NAC for Post-ERCP Pancreatitis Prevention
NCT03708458Phase 4Unknown
- Sponsor
- Grigore T. Popa University of Medicine and Pharmacy
- Start
- Apr 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of indomethacin, acetylcysteine in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP), sponsored by Grigore T. Popa University of Medicine and Pharmacy. Status: unknown.
02
Drugs
indomethacinacetylcysteine
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on NCT03708458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03708458.